I share Mr. Balsillie's concerns that there are gaps in the legislation. I think the legislation as it's currently drafted does a very good job with respect to monitoring the acquisition of controls of Canadian entities. In certain instances, there may be jurisdictional scope for an acquisition of an intellectual property asset to be caught by the Investment Canada Act and reviewed by it.
I think it would be worthwhile to do exactly what Mr. Balsillie says and think about whether or not there are any gaps. I think there are arguably gaps with respect to its scope, and that is with respect to transactions that do not involve acquisitions of control, or acquisitions of ownership interests in other entities or assets. There could be situations where technology transfers undermine national security but are not caught by the jurisdictional scope of the act.
I do think the act does a great job, and my response to the question that the committee is considering in these hearings, with respect to whether or not there ought to be threshold reviews or moratoriums, is that the act doesn't need to be changed.
With respect to non-COVID-specific issues that are broader in nature, should we periodically re-evaluate the act and whether or not it needs to be upgraded? Yes, I think we should.